|
|
News & Events
News
|
17-Feb-2011
(Quantitative) Structure-Activity Relationships or (Q)SARs are methods for estimating properties of a chemical from its molecular structure. The QSAR Toolbox is a software intended to be used by governments, the chemical industry and other stakeholders to apply (Q)SARs to fill data gaps needed for assessing the hazards of chemicals. This updated version 2.1 contains a number of new functionalities and bug fixes. The release is part of a collaboration between OECD and the European Chemicals Agency.
|
|
03-Feb-2011
A guidance document for using the OECD QSAR Toolbox to fill data gaps for genotoxicity and is now available. The QSAR Toolbox is a software application intended to be used by governments, industry and other stakeholders to fill gaps in (eco)toxicity data needed for assessing the hazards of chemicals. This new document specifically provides guidance on how to use the Toolbox to group chemicals to fill data gaps for genotoxicity and carcinogenicity of chemicals.
|
|
20-Dec-2010
This first edition of Health at a Glance: Asia/Pacific presents a set of key indicators of health status, the determinants of health, health care resources and utilisation, and health care expenditure and financing across 27 Asia/Pacific countries.
|
|
15-Dec-2010
In this issue: details on the Health Ministerial meeting, Balancing quality and privacy in health care, Fit not Fat in the media, Health challenges after the crisis, Making Reform Happen, and our new publications.
|
|
07-Dec-2010
A special edition of Health at a Glance: Europe is released on 7 December 2010. It focuses on health issues across the 27 European Union member states, three European Free Trade Association countries (Iceland, Norway and Switzerland) and Turkey. It gives readers a better understanding of the factors that affect the health of populations and the performance of health systems in these countries. Its 42 indicators present comparable data covering a wide range of topics, including health status, risk factors, health workforce and health expenditure.
|
|
06-Dec-2010
What are the potential economic impacts of nanotechnology, how are companies using nanotechnology for innovation, and what are the key challenges in its commercialisation? These are some of the questions that this book addresses, based on company case studies in several countries.
|
Top of page
|
Policy Brief - Health
|
